United States: FDA Issues A Final Rule On Biologics License Applications, Investigational New Drug Applications And Master Files - Goodwin Procter LLP

United States: FDA Issues A Final Rule On Biologics License Applications, Investigational New Drug Applications And Master Files - Goodwin Procter LLP

Mondaq

Published

On February 12, the FDA issued a final rule regarding the use of Drug Master Files ("DMF") in Biologics License Applications.

Full Article